trending Market Intelligence /marketintelligence/en/news-insights/trending/u-molgK12jO5ebCoQf6Thw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Akers Biosciences closes $6.9M common stock, warrants offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Akers Biosciences closes $6.9M common stock, warrants offering

Akers Biosciences Inc. closed its underwritten public offering, including the full exercise of the underwriter's over-allotment option, for total gross proceeds of $6.9 million.

The company issued class A units consisting of 21.5 million of its common shares and warrants to buy 21.5 million of its common shares priced at 15 cents per class A unit.

The company also issued class B units consisting of 3,675 shares of its series B convertible preferred stock, with a stated value of $1,000, and convertible into 24.5 million common shares and warrants to buy 24,500,001 common shares at $1,000 per class B unit.

The warrants have an exercise price of 18.75 cents, will be exercisable upon issuance and will expire five years from the date of issuance.

The funds raised will be used for working capital, product development, marketing activities, expanding our internal sales organization and further developing sales channels and other capital expenditures.

Joseph Gunnar & Co. LLC acted as sole book-running manager for the offering.